您的当前位置:首页正文

NITROSATED AND NITROSYLATED NEBIVOLOL AND ITS META

2022-03-21 来源:客趣旅游网
专利内容由知识产权出版社提供

专利名称:NITROSATED AND NITROSYLATED

NEBIVOLOL AND ITS METABOLITES,COMPOSITIONS AND METHODS OF USE

发明人:GARVEY, David, S.申请号:EP02766876.3申请日:20020501公开号:EP1406608A2公开日:20040414

摘要:The invention describes novel nitrosated and/or nitrosylated nebivolol, novelnitrosated and/or nitrosylated metabolites of nebivolol and novel compositionscomprising at least one nitrosated and/or nitrosylated nebivolol and/or at least onenitrosated and/or nitrosylated metabolite of nebivolol, and optionally, at least one nitricoxide donor and/or at least one antioxidant or a pharmaceutically acceptable saltthereof, and/or at least one compound used to treat cardiovascular disease or a

pharmaceutically acceptable salt thereof, and/or at least one nitrosated compound usedto treat cardiovascular diseases. The invention also provides novel compositionscomprising nebivolol and/or at least one metabolite of nebivolol and at least one nitricoxide donor, and, optionally, at least one antioxidant or a pharmaceutically acceptablesalt thereof, and/or at least one compound used to treat cardiovascular diseases or apharmaceutically acceptable salt thereof, and/or at least one nitrosated compound usedto treat cardiovascular diseases. The compounds and compositions of the invention canalso be bound to a matrix. The nitric oxide donor is a compound that donates, transfersor releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing

factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxidesynthase and may preferably be isosorbide dinitrate and/or isosorbide mononitrate. Theantioxidant may preferably be a hydralazine compound or a pharmaceutically acceptablesalt thereof. The invention also provides methods for treating and/or preventing vasculardiseases characterized by nitric oxide insufficiency; and for treating and/or preventingRaynaud's syndrome; and for treating and/or preventing cardiovascular diseases ordisorders.

申请人:Nitromed, Inc.

地址:12 Oak Park Drive Bedford, MA 01730 US

国籍:US

代理机构:Wright, Robert Gordon McRae

更多信息请下载全文后查看

因篇幅问题不能全部显示,请点此查看更多更全内容